Translational neuroscience
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- P1VITAL LIMITED
UK SME specializing in predictive biomarkers and patient stratification for psychiatric and neurological drug development.
“PRISM 2 explicitly lists translational neuroscience and transdiagnostic approaches as keywords.”
SMEUK4 projects - SBGNEURO LTD
UK neuroscience SME specialising in digital biomarkers and patient stratification for psychiatric and neurodegenerative drug development.
“PRISM 2 names translational neuroscience directly; the PRISM programme as a whole is designed to translate research findings into clinically usable stratification tools.”
PrimarySMEUK2 projects - BIOTRIAL RESEARCH
French CRO providing clinical trial and biomarker expertise to EU consortia in metabolic disease and neuropsychiatric research.
“PRISM 2's focus on intermediate stratified markers and translational neuroscience indicates an expanding capability in moving mechanistic findings toward clinical application.”
SMEFR2 projects